The high cost of cutting-edge treatments threatens to keep precision medicine, one of the most celebrated areas in cancer care, out of reach for many patients.
As the number of mobile health apps surged to a record 325,000 in 2017, app performance is going largely unpoliced.
Health insurance doesn’t typically cover fertility preservation care, so patients and their families may be deterred by the cost.
Surveys show that the public are optimistic about genome editing for curing diseases, but there can also be a lack of trust about how this technology will be used.
The Trump administration faces mounting pressure from conservative lawmakers and abortion opponents to halt the use of tissue obtained from aborted fetuses.
Insurers could use these apps to track all the activities you do while wearing the smartwatch, including steps walked, heart rate, even when you’re having sex.
More than 1 in 10 have had genetic tests ordered by a doctor or ordered them directly, a new survey finds. Others say they’re interested, but many have concerns.
Courts have ruled states cannot withhold potentially life-saving but expensive medications from Medicaid beneficiaries and prison inmates who have hepatitis C.
The center’s pathologists have objected to the deal, saying it is unfair that the founders received equity that relies on the pathologists’ expertise and work
Universities that sell access to their biobanks to private companies should tell patients and be transparent about how profits are used, a new survey shows.